News & Analysis on Clinical Trial Services & Contract Research And Development
Chiron and the multiple myeloma research consortium have announced the initiation of a phase I clinical trial for CHIR-258 - the first drug candidate to undergo clinical study through the MMRC - an organisation that integrates leading academic...
Researchers have discovered that a certain virus appears to cloak itself with a recently discovered gene-silencing device to evade detection and destruction by immune cells. The study is the first to show how a virus uses the gene silencing machinery...
The use of DNA as a vaccine has been an exciting but elusive prospect in drug development for many years, held back by problems with effectivness and difficulties in production. But this could be about to change, reports Phil Taylor.